StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) company profile

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

About USANA Health Sciences

Medicinal Chemicals & Botanical Products, SIC 2833

USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, and personal care products. The company organizes its operations into two reportable segments: Core nutritional and Hiya direct-to-consumer. Its offerings include targeted supplements, core vitamin and mineral supplements, meal replacement shakes, snack bars, skincare lines, and children's wellness items like chewable multivitamins and probiotics. Core nutritional products serve Brand Partners—who act as independent distributors and purchase for personal use—and Preferred Customers, who buy solely for personal consumption. Hiya serves retail consumers directly, primarily through a subscription model.

The company operates across twenty-five geographic markets worldwide within two main regions: Asia Pacific and Americas and Europe. Its business in China is conducted through BabyCare, which maintains manufacturing facilities in Beijing and Tianjin. USANA maintains corporate headquarters, alongside manufacturing and quality control facilities, in Salt Lake City, Utah.

Summary of the business section of USANA Health Sciences's latest annual report, written by StockData.

Company profile

Company

Legal name
USANA Health Sciences Inc
Founded
1992
Headquarters
Salt Lake City, UT
Address
3838 West Parkway Blvd. 84120-6336
Phone
(801) 954-7100
Employees
1,570, Jan 3, 2026
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
Utah
Fiscal year ends
January 3
Auditor
KPMG LLP, Salt Lake City, Utah

Stock & identifiers

Ticker
USNA
Exchange
NYSE
Shares outstanding
18M, Aug 11, 2026
Public float
$328.00M, Jun 27, 2025
Filer category
Accelerated filer
Stock splits
2-for-1, Nov 23, 2016; 2-for-1, Oct 31, 2003; 2-for-1, Aug 4, 1998
SEC CIK
896264
CUSIP
90328M107
ISIN
US90328M1071
FIGI
BBG000BX28M0
Share class FIGI
BBG001S79BP0
LEI
549300YTURXE814MAH96
EIN
87-0500306

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Peter BenedictCHIEF INFORMATION OFFICER422
Kathryn Michelle ArmstrongCHIEF SCIENTIFIC OFFICER3,989
Brent NeidigCHIEF COMMERCIAL OFFICER0
Paul A. JonesCHIEF PEOPLE OFFICER0
G. Doug IiekkingCHIEF FINANCIAL OFFICER708
Joshua FoukasCHIEF LEGAL OFFICER0
Kevin GuestCEO & EXEC. CHAIRMAN OF BOARD49,070
Walter NootCHIEF OPERATING OFFICER9,256
David Mulham MulhamCHIEF SALES OFFICER8,387
Jim BrownCEO & PRESIDENT18,753
J. Scott NixonDirector13,077
Peggie PelosiDirector6,758
John Turman FlemingDirector7,494
Frederic J. WinssingerDirector11,365
Xia DingDirector9,306
Gilbert A. FullerDirector3,264
Timothy E. WoodDirector13,061

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$4.34M$2.39M$1.58M$25$49
FY2024$3.36M$2.07M$1.36M$46$94
FY2023
Mr.Brown
$2.47M$2.38M$1.33M$70$47
FY2023
Mr.Guest
$3.91M$3.84M$1.33M$70$47
FY2022$3.75M-$592.26K$1.43M$69$62
FY2021$3.91M$5.96M$1.57M$131$97

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Jim H. Brown
Chief Executive Officer & President (former)
$821.23K–$3.15M$339.17K$32.21K$4.34M+29%
G. Douglas Hekking
Chief Financial Officer
$568.53K$175.00K$855.68K$83.01K$16.40K$1.70M+18%
Walter Noot
Chief Operating Officer
$564.90K$196.08K$850.24K$82.48K$25.60K$1.72M+20%
Joshua Foukas
Chief Legal Officer & General Counsel
$500.57K$175.00K$753.40K$73.08K$12.25K$1.51M+19%
Brent Neidig
Chief Commercial Officer
$513.52K–$772.88K$77.03K$12.25K$1.38M+6%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of January 3, 2026, we had approximately 1,570 employees working in 22 countries worldwide, as measured by full-time equivalency.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?